Latest news
Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001 - GlobeNewswireGlobeNewswire · Wed, 05 Aug 2026 10:50:00 GMTEton Pharmaceuticals Announces Submission of Prior Approval - GlobeNewswireGlobeNewswire · Wed, 29 Jul 2026 10:50:00 GMT